Network origin in Roger Belusa first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Roger Belusa via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABLYNX | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Technical University of Denmark | College/University | Graduate Degree | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree | |
| University of Antwerp | College/University | Doctorate Degree | |
Highlight Therapeutics SL
 Highlight Therapeutics SL Pharmaceuticals: MajorHealth Technology Highlight Therapeutics develops ribonucleic acid-based therapies and novel targets in cancer and immune cells. Its product BO-112, induces immunogenic cell death in solid tumors and simultaneously activates the innate immune system to ensure optimal antigen processing and presentation to the adaptive immune system. The company was founded by Damia tormo Carulla and is headquartered in Paterna, Spain. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| Belgium | 4 |
| Spain | 3 |
| Denmark | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Most connected contacts
- Stock Market
- Insiders
- Roger Belusa
- Company connections
